BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 23259994)

  • 1. The Treatment of Heterotopic Human Colon Xenograft Tumors in Mice with 5-Fluorouracil Attached to Magnetic Nanoparticles in Combination with Magnetic Hyperthermia Is More Efficient than Either Therapy Alone.
    Dabaghi M; Quaas R; Hilger I
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32916798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine enhances the anti-tumor effect of 5-fluorouracil via increasing the production of reactive oxygen species in hepatocellular carcinoma.
    Wang Z; Gu C; Wang X; Lang Y; Wu Y; Wu X; Zhu X; Wang K; Yang H
    Med Oncol; 2019 Oct; 36(12):97. PubMed ID: 31664534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFκB-Associated Pathways in Progression of Chemoresistance to 5-Fluorouracil in an In Vitro Model of Colonic Carcinoma.
    Körber MI; Staribacher A; Ratzenböck I; Steger G; Mader RM
    Anticancer Res; 2016 Apr; 36(4):1631-9. PubMed ID: 27069140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of colon cancer reveals a broad molecular repertoire in 5-fluorouracil resistance.
    Schmidt WM; Kalipciyan M; Dornstauder E; Rizovski B; Sedivy R; Steger GG; Müller MW; Mader RM
    Int J Clin Pharmacol Ther; 2003 Dec; 41(12):624-5. PubMed ID: 14692722
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-resistance of 5-fluorouracil-resistant colon carcinoma in vitro.
    Ratzenboeck IE; Bartl B; Forstner B; Kalipciyan M; Steger GG; Mader RM
    Int J Clin Pharmacol Ther; 2011 Jan; 49(1):81-2. PubMed ID: 21176738
    [No Abstract]   [Full Text] [Related]  

  • 6. Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction.
    Liu B; Xu T; Xu X; Cui Y; Xing X
    Mol Cell Biochem; 2018 Dec; 449(1-2):285-294. PubMed ID: 29761248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of caspases primes colon cancer cells for 5-fluorouracil-induced TNF-α-dependent necroptosis driven by RIP1 kinase and NF-κB.
    Oliver Metzig M; Fuchs D; Tagscherer KE; Gröne HJ; Schirmacher P; Roth W
    Oncogene; 2016 Jun; 35(26):3399-409. PubMed ID: 26522725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB addiction and resistance to 5-fluorouracil in a multi-stage colon carcinoma model.
    Körber MI; Klingenbrunner S; Bartsch R; Steger GG; Mader RM
    Int J Clin Pharmacol Ther; 2013 Jan; 51(1):35-7. PubMed ID: 23259994
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular biological analysis of 5-fluorouracil sensitivity in colorectal neoplasm].
    Kubota T; Yoshinare K; Kabeshima Y; Watanabe M; Kitajima M
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():321-4. PubMed ID: 14574903
    [No Abstract]   [Full Text] [Related]  

  • 10. The relationship between tumor metabolism and 5-fluorouracil resistance.
    Hu J; Li A; Guo Y; Ma T; Feng S
    Biochem Pharmacol; 2023 Dec; 218():115902. PubMed ID: 37922975
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of pH in tumor-trapping of the anticancer drug 5-fluorouracil.
    McSheehy PM; Stubbs M; Griffiths JR
    Adv Enzyme Regul; 2000; 40():63-80. PubMed ID: 10828346
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.